Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06949072 · ClinicalTrials.gov registry record · NA
A Clinical Study to Assess an Experimental Dentifrice in an Experimental Model of Early Stage Caries
A NA study, sponsored by HALEON.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT06949072 is a NA study that has completed, run by HALEON. The registered enrollment target is 47 participants.
The verdict
NCT06949072, a NA study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate the relative efficacy of an experimental dentifrice containing 1150 parts per million (ppm) fluoride (as sodium fluoride \[NaF\]) to remineralize early stage caries type lesions in an in situ model compared to a negative control and a reference dentifrice.
Interventions
- DRUG Test Dentifrice
- DRUG Reference Dentifrice
- DRUG Negative Control Dentifrice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2025-04-28 |
| Est. Completion | 2025-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06949072
The ClinicalTrials.gov registry entry for NCT06949072 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Test Dentifrice is the first listed.
NCT06949072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06949072 about?
NCT06949072 is a clinical study titled "A Clinical Study to Assess an Experimental Dentifrice in an Experimental Model of Early Stage Caries". The aim of this study is to evaluate the relative efficacy of an experimental dentifrice containing 1150 parts per million (ppm) fluoride (as sodium fluoride \[NaF\]) to remineralize early stage caries type lesions in an in situ model compared to a negative control and a reference dentifrice.
What is the current status of trial NCT06949072?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2025-04-28. Estimated completion is 2025-09-11.
What interventions are being tested in trial NCT06949072?
The interventions under investigation include: Test Dentifrice (DRUG), Reference Dentifrice (DRUG), Negative Control Dentifrice (DRUG).
Who is sponsoring clinical trial NCT06949072?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.